Human Fas / TNFRSF6 / CD95 Protein, Fc Tag (MALS verified)

用户评价
货号-规格
价格
Qty.
FAS-H5252-100ug
¥3005.00
FAS-H5252-1mg
¥18550.00
合计0件 产品金额¥ 0

产品详情

  • 分子别名(Synonym)

    FAS, ALPS1A, APO1, APT1, CD95, FAS1, FASTM, TNFRSF6, FasR

  • 表达区间及表达系统(Source)

    Human Fas Protein, Fc Tag (FAS-H5252) is expressed from human 293 cells (HEK293). It contains AA Gln 26 - Asn 173 (Accession # AAH12479.1).

    Predicted N-terminus: Gln 26

    Request for sequence
  • 蛋白结构(Molecular Characterization)

    Fas Structure

    This protein carries a human IgG1 Fc tag at the C-terminus.

    The protein has a calculated MW of 42.8 kDa. The protein migrates as 50-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • 内毒素(Endotoxin)

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • 纯度(Purity)

    >95% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • 制剂(Formulation)

    Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • 重构方法(Reconstitution)

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • 存储(Storage)

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

推荐产品

数据展示

  • 电泳(SDS-PAGE)

    Fas SDS-PAGE

    Human Fas Protein, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

  • SEC-MALS

    Fas SEC-MALS

    The purity of Human Fas Protein, Fc Tag (Cat. No. FAS-H5252) is more than 95% and the molecular weight of this protein is around 93-110 kDa verified by SEC-MALS.

    Report
  • 活性(Bioactivity)-ELISA

     Fas ELISA

    Immobilized Human Fas Ligand, His Tag, premium grade (Cat. No. FAL-H5241) at 2 μg/mL (100 μL/well) can bind Human Fas Protein, Fc Tag (Cat. No. FAS-H5252) with a linear range of 0.3-5 ng/mL (QC tested).

    Protocol

用户评价
发表评论

背景介绍

The Fas is also known as FAS receptor (FasR), apoptosis antigen 1 (APO-1 or APT), cluster of differentiation 95 (CD95) or tumor necrosis factor receptor superfamily member 6 (TNFRSF6). is a death receptor on the surface of cells that leads to programmed cell death (apoptosis). It is one of two apoptosis pathways, the other being the mitochondrial pathway. FasR is located on chromosome 10 in humans and 19 in mice. Similar sequences related by evolution (orthologs) are found in most mammals. Fas forms the death-inducing signaling complex (DISC) upon ligand binding. Membrane-anchored Fas ligand trimer on the surface of an adjacent cell causes trimerization of Fas receptor. This event is also mimicked by binding of an agonistic Fas antibody, though some evidence suggests that the apoptotic signal induced by the antibody is unreliable in the study of Fas signaling. To this end, several clever ways of trimerizing the antibody for in vitro research have been employed.Upon ensuing death domain (DD) aggregation, the receptor complex is internalized via the cellular endosomal machinery. This allows the adaptor molecule FADD to bind the death domain of Fas through its own death domain. Recently, Fas has also been shown to promote tumor growth, since during tumor progression, it is frequently downregulated or cells are rendered apoptosis resistant. Cancer cells in general, regardless of their Fas apoptosis sensitivity, depend on constitutive activity of Fas. This is stimulated by cancer-produced Fas ligand for optimal growth.

前沿进展

 
药物研发进展
  • 英文全称:

    Apoptosis-mediating surface antigen FAS

  • 中文全称:

    Fas抗原

  • 种类:

  • 上市药物数量:

    1 详情

  • 临床药物数量:

    1 详情

  • 最高研发阶段:

    批准上市

联系我们
项目合作
查看更多项目
实验案例分析
查看更多案例分析
  • 产品基础信息
  • 产品详情
  • 推荐产品
  • 数据展示
  • 用户评价
  • 背景介绍